The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Hims & Hers Health Inc shares valued at $798,977 were sold by Carroll Patrick Harrison on Mar 18 ’25. At $34.31 per share, Carroll Patrick Harrison sold 23,287 shares. The insider’s holdings dropped to 209,661 shares worth approximately $6.89 million following the completion of this transaction.
Also, Dudum Andrew sold 128,127 shares, netting a total of over 4,353,124 in proceeds. Following the sale of shares at $33.98 each, the insider now holds 173,655 shares.
Before that, Dudum Andrew had sold 78,760 shares from its account. In a trade valued at $2,666,199, the Chief Executive Officer traded Hims & Hers Health Inc shares for $33.85 each. Upon closing the transaction, the insider’s holdings decreased to 78,760 shares, worth approximately $3.12 million.
As published in a research note from Morgan Stanley on February 18, 2025, Hims & Hers Health Inc [HIMS] has been rated down from an Overweight to an Equal-weight and the price target has been revised to $60 from $42. Analysts at Citigroup downgraded the stock from ‘”a Neutral”‘ to ‘”a Sell”‘ outlook in a report released in early January. As of January 07, 2025, BTIG Research has initiated its “Buy” rating for HIMS. Earlier on December 17, 2024, Morgan Stanley initiated its rating. Their recommendation was “an Overweight” for HIMS stock.
Analyzing HIMS Stock Performance
During the last five days, there has been a surge of approximately 4.22%. Over the course of the year, Hims & Hers Health Inc shares have jumped approximately 35.94%. Shares of the company reached a 52-week high of $72.98 on 02/19/25 and a 52-week low of $24.07 on 01/10/25. A 50-day SMA is recorded $38.34, while a 200-day SMA reached $25.74.
Support And Resistance Levels for Hims & Hers Health Inc (HIMS)
According to the 24-hour chart, there is a support level at 32.07, which, if violated, would cause prices to drop to 31.27. In the upper region, resistance lies at 33.96. The next price resistance is at 35.05. RSI (Relative Strength Index) is 42.40 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.48, which suggests the price will decrease in the coming days. Percent R is at 87.87%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
